Literature DB >> 28483527

Immuno-PCR with digital readout.

Hendrik Schröder1, Maximilian Grösche2, Michael Adler1, Mark Spengler3, Christof M Niemeyer4.   

Abstract

Immuno-PCR (IPCR) combines the versatile ELISA antigen detection with ultrasensitive PCR signal amplification, thereby enabling the highly sensitive detection of a broad range of targets with a typically very large dynamic detection range. The quantification of the antigen is usually achieved by real-time PCR, which provides a correlation between the target concentration and amplified DNA marker. We here report on the implementation of digital droplet PCR as a means for direct quantification of DNA copies to enable the highly sensitive detection of protein biomarkers. To this end, two alternative approaches, based on either magnetic microbead-based IPCR or a microplate-release IPCR were tested. The latter format worked well and revealed an extraordinary high robustness and sensitivity. While rtIPCR already fulfills typical immunoassay acceptance criteria, ddIPCR enables improved accuracy and precision of the assay because signal response and analyte concentrations are directly correlated. The utility of the novel ddIPCR technology is demonstrated at the example of two cytokines, interleukin 2 and interleukin 6 (IL2, IL6, respectively), with an overall average CV% of 5.0 (IL2) and 7.4 (IL6).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; Biomarker; Digital droplet polymerase chain reaction; Immuno PCR; Immunoassays; Ultra-sensitive

Mesh:

Substances:

Year:  2017        PMID: 28483527     DOI: 10.1016/j.bbrc.2017.04.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.

Authors:  Harald Hampel; Sid E O'Bryant; José L Molinuevo; Henrik Zetterberg; Colin L Masters; Simone Lista; Steven J Kiddle; Richard Batrla; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2018-11       Impact factor: 42.937

Review 2.  [Research advances of high-throughput cell-based drug screening systems based on microfluidic technique].

Authors:  Yixiao Liang; Jianzhang Pan; Qun Fang
Journal:  Se Pu       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.